Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 25;47(1):211.
doi: 10.1186/s13052-021-01150-0.

Prevention of recurrent respiratory infections : Inter-society Consensus

Affiliations

Prevention of recurrent respiratory infections : Inter-society Consensus

Elena Chiappini et al. Ital J Pediatr. .

Abstract

Recurrent respiratory infections (RRIs) are a common clinical condition in children, in fact about 25% of children under 1 year and 6% of children during the first 6 years of life have RRIs. In most cases, infections occur with mild clinical manifestations and the frequency of episodes tends to decrease over time with a complete resolution by 12 years of age. However, RRIs significantly reduce child and family quality of life and lead to significant medical and social costs.Despite the importance of this condition, there is currently no agreed definition of the term RRIs in the literature, especially concerning the frequency and type of infectious episodes to be considered. The aim of this consensus document is to propose an updated definition and provide recommendations with the intent of guiding the physician in the complex process of diagnosis, management and prevention of RRIs.

Keywords: Children; Immune system; Prevention; Recurrent respiratory infections.

PubMed Disclaimer

Conflict of interest statement

The competing interests of the panel members are reported as following:

-EC: Valeas Spa Italia.

-RC: Abbvie, Aboca, Chiesi, Glaxosmitkline, Omron, Ailiquide.

-PM: Valeas Spa Italia, OM Pharma S.A. e DMG.

-RM: Grunenthal.

-FS: Chiesi; AbbVie; Valeas.

The other authors declare that they have no competing interests.

References

    1. de Martino M, Ballotti S. The child with recurrent respiratory infections: normal or not? Pediatr Allergy Immunol. 2007;18(Suppl 18):13–18. doi: 10.1111/j.1399-3038.2007.00625.x. - DOI - PubMed
    1. Toivonen L, Karppinen S, Schuez-Havupalo L, Teros-Jaakkola T, Vuononvirta J, Mertsola J, He Q, Waris M, Peltola V. Burden of recurrent respiratory tract infections in children: a prospective cohort study. Pediatr Infect Dis J. 2016;35(12):e362–e369. doi: 10.1097/INF.0000000000001304. - DOI - PubMed
    1. De Benedictis FM, Bush A. Recurrent lower respiratory tract infections in children. BMJ. 2018;362:k2698. doi: 10.1136/bmj.k2698. - DOI - PubMed
    1. Brook I. Dynamics of nasopharyngitis in children. Otolaryngol Head Neck Surg. 2000;122(5):696–700. doi: 10.1016/S0194-5998(00)70199-9. - DOI - PubMed
    1. Steele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160(1):83–94. doi: 10.1093/infdis/160.1.83. - DOI - PubMed

Publication types

MeSH terms